Effects of Daily Nitrate Consumption on Oral Bacteria Composition, Blood Pressure and Vascular Function
REBOC2
Investigation of the Effects of Daily Nitrate Consumption on Oral Bacteria Composition, Blood Pressure and Vascular Functio
1 other identifier
interventional
28
1 country
1
Brief Summary
Diseases of the heart and blood vessels, including raised blood pressure, are one of the leading causes of death worldwide. Higher intakes of dietary nitrate, found abundantly in root vegetables such as beetroot, have been shown to have health benefits including lowering blood pressure and improving the elasticity of blood vessels. Bacteria which reside in the mouth and those in the gastrointestinal tract play an important role in converting dietary nitrate to nitrite and nitric oxide (a chemical which promotes the relaxation of blood vessels). In particular, removal of oral bacteria by using antiseptic mouthwash is accompanied by an increase in blood pressure in subjects with normal blood pressure, even after consuming nitrate-rich foods. To date, very little is known about the role of these oral bacteria in the control of blood pressure, and if there are any differences in bacterial composition between individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 1, 2018
CompletedStudy Start
First participant enrolled
December 1, 2018
CompletedFirst Posted
Study publicly available on registry
December 24, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedApril 12, 2024
April 1, 2024
2 years
November 1, 2018
April 11, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Change in blood pressure measure
Systolic blood pressure, diastolic blood pressure and pulse pressure
Before and after each 8 week intervention
Change in oral bacteria composition
Oral bacteria composition determined using next generation sequencing.
Before and after each 8 week intervention
Secondary Outcomes (12)
Change in vascular reactivity
Before and after each 8 week intervention
Change in Nox concentrations in serum, urine and saliva
Before and after each 8 week intervention
Change in gut bacteria composition
Before and after each 8 week intervention
Change in fasting lipid profile
Before and after each 8 week intervention
Change in C-reactive protein
Before and after each 8 week intervention
- +7 more secondary outcomes
Study Arms (2)
Nitrate-rich Beetroot juice
ACTIVE COMPARATORNitrate-rich beetroot juice equivalent to 3.7 mg nitrate per kg body weight daily for 8 weeks.
Placebo beetroot juice
PLACEBO COMPARATORPlacebo beetroot juice (equivalent volume to the amount of nitrate-rich beetroot juice consumed) daily for 8 weeks.
Interventions
James White Drinks Limited beetroot juice (0.4-0.45 g nitrate/70 ml drink).
James White Drinks Limited Placebo beetroot juice (0 nitrate/70 ml drink).
Eligibility Criteria
You may qualify if:
- Male and female;
- A signed consent form;
- Blood pressure \<140/90 mm Hg;
- BMI range 18.5 - 39.9 kg/m2;
- Age 18-64 years;
- Non-smoking;
- Not taking blood pressure lowering medication or using medications known to influence vascular function such as a glyceryl trinitrate (GTN) spray;
- No recent (within 3 months) or current use of antibiotics.
You may not qualify if:
- Diagnosed with a chronic illness;
- Anaemia defined as a haemoglobin \< 115 g/l for women and \<130 g/l for men;
- Individuals with food allergies or allergies to medicated mouthwash or ingredients in the oral products;
- Requirements to take long-term medication active on the oral cavity including prebiotics and probiotics or have taken antibiotics within the last 3 months;
- Gingivitis diagnosis, or periodontal disease or chronic oral complaints or existing oral pathology.
- Less than four natural (enamel) buccal surfaces of upper molars available;
- Presence of fixed or removable oral appliances (e.g., dentures, orthodontic wires); xerostomia (a persistent dry mouth) diagnosis;
- Current smoker;
- Already participating in a dietary intervention study or clinical trial;
- Excessive alcohol consumption (\> 14 units/wk);
- Females who are pregnant or lactating;
- Individuals not willing to give up using mouthwash or change their dental hygiene routine. Regular consumption or use of xylitol-based products such as toothpaste and chewing gum.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Readinglead
- Saudi Cultural Bureaucollaborator
Study Sites (1)
Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, University of Reading
Reading, Berkshire, RG6 6AP, United Kingdom
Study Officials
- PRINCIPAL INVESTIGATOR
Julie A Lovegrove, BSc, PhD
University of Reading
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Human Nutrition, Head of the Hugh Sinclair Unit of Human Nutrition
Study Record Dates
First Submitted
November 1, 2018
First Posted
December 24, 2018
Study Start
December 1, 2018
Primary Completion
December 1, 2020
Study Completion
December 1, 2021
Last Updated
April 12, 2024
Record last verified: 2024-04